General Information of the Molecule (ID: Mol05984)
Name
DPP10-AS1 ,Homo sapiens
Molecule Type
Long non-coding RNA
Sequence
AGCTCCGCCACTGCGCGCGCTCCAGCGCCCCAGAAGGCAGGGGGCAGCCCGGGGACCGGG
GTCCCGGAGCCCCGTGGGAGGCGGGCAACACCTGTCGGGACCCGAGGGCGTGTCTGAGAT
TGTGGCCTGAGGTGCTGCGCCTTCCGATCCGGGGCAGCGGGCGTCCTGTAGCTGCGCCTT
CCGAATCCAGCCCAGATTCTCCTACCAGCTGCTTGGGTCACGTCGGTGGAACTCCTAAAG
GGATGCCTTCAAAATGTGTGAATAAGCTTCAATCAGACTGCCCTTCCCAAAGAAAATAAC
TATAAATGCTGGAAAAACTACAAAACAGCCACCTGAAGGCACTGGCGAGAGACAAAAGCA
AGCAAATTCTGGAGAAGAGTCAACACTTGGAAGAAGGGAGCTGCACTGGGTACATGGGGA
AGGAACAGTGTCTCTGCATGAGAATGGCCAAAGAACAAGATACATTTCCCCGTGGAGAGC
AATCCTAGAGAGAGGGAAGCATGGGTCAGAATAAGGTGTACTGGCCCCAGGGTAATAGCA
TGTATTTCTGTTGCATTGGTGTTTCCAAAATAATGCTTCGGTTCCAAGTTTCAGGAATTG
GTTGGGGGAGCATGGGGATCATACAGTGATTCAGGAGCTTCCTTGCAAGTAAGTGAGTGA
GCCAATCAAATAATTTATGTTTAAATCTTTCACTGTGTTAAATGTTGAAAAATAAAGCAA
GTGAATTCCAAAAAAAAAAAAAAA
    Click to Show/Hide
        Click to Show/Hide the Complete Species Lineage
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Type(s) of Resistant Mechanism of This Molecule
  EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Enzalutamide
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
  Epigenetic Alteration of DNA, RNA or Protein (EADR) Click to Show/Hide
Disease Class: Prostate cancer [ICD-11: 2C82.0] [1]
Resistant Disease Prostate cancer [ICD-11: 2C82.0]
Resistant Drug Enzalutamide
Molecule Alteration Expression
Up-regulation
Experimental Note Revealed Based on the Cell Line Data
In Vitro Model LNCaP cells Prostate Homo sapiens (Human) CVCL_0395
C4-2B cells Prostate Homo sapiens (Human) CVCL_4784
Experiment for
Molecule Alteration
Western blot
Experiment for
Drug Resistance
MTT assay
Mechanism Description This gene is up-regulated in enzalutamide-resistance cells
References
Ref 1 Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab ResistanceMol Cancer Ther. 2018 Feb;17(2):521-531. doi: 10.1158/1535-7163.MCT-17-0575. Epub 2017 Nov 20.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.